Derek Taller

On April 29, 2025, the Securities and Exchange Commission filed charges against Derek Taller, a former New York-based investment adviser, for allegedly defrauding investors in two private funds by misusing investor money, concealing conflicts of interest, and making false statements in offering materials.

According to the SEC’s complaint, between March 2018 and January 2024, Taller served as the principal officer and investment adviser for two funds: StHealth Capital Investment Corporation and Vision BioBanc Holdings, LLC. In 2020, Taller allegedly provided offering documents to prospective investors in Vision Holdings that falsely claimed the fund was overseen by an independent board and subject to financial audits. In reality, Vision Holdings had no independent auditor and Taller was its sole active board member for much of the time.

The SEC further alleges that in May 2020, Taller acquired an undisclosed interest in a third-party startup, then directed both StHealth Capital and Vision Holdings to loan the startup $2 million without informing investors of his personal interest in the borrower. From mid-2020 through early 2021, he allegedly funneled more than $21 million in additional loans from the funds to the startup and its affiliates while actively concealing his conflicting business ties. Taller is also accused of misappropriating hundreds of thousands of dollars from the funds for personal use.

The SEC is seeking permanent and conduct-based injunctions, an officer-and-director bar, disgorgement, and civil penalties.

If you invested with Derek Taller, StHealth Capital Investment Corporation, or Vision BioBanc Holdings and believe you may have suffered losses, contact the attorneys at ChapmanAlbin. We represent investors nationwide in recovering losses caused by investment fraud and adviser misconduct.

Call (877) 410-8172 or visit www.chapmanalbin.com for a free consultation.